Cargando…
Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation
Hotspot mutations of Ras drive cell transformation and tumorigenesis. Less frequent mutations in Ras are poorly characterized for their oncogenic potential. Yet insight into their mechanism of action may point to novel opportunities to target Ras. Here, we show that several cancer-associated mutatio...
Autores principales: | Šolman, Maja, Ligabue, Alessio, Blaževitš, Olga, Jaiswal, Alok, Zhou, Yong, Liang, Hong, Lectez, Benoit, Kopra, Kari, Guzmán, Camilo, Härmä, Harri, Hancock, John F, Aittokallio, Tero, Abankwa, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563131/ https://www.ncbi.nlm.nih.gov/pubmed/26274561 http://dx.doi.org/10.7554/eLife.08905 |
Ejemplares similares
-
Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering
por: Blaževitš, Olga, et al.
Publicado: (2016) -
ASPP2 Is a Novel Pan-Ras Nanocluster Scaffold
por: Posada, Itziar M. D., et al.
Publicado: (2016) -
Cancer stem cell drugs target K-ras signaling in a stemness context
por: Najumudeen, A K, et al.
Publicado: (2016) -
Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner
por: Posada, Itziar M.D., et al.
Publicado: (2017) -
Structural analysis of autoinhibition in the Ras-specific exchange factor RasGRP1
por: Iwig, Jeffrey S, et al.
Publicado: (2013)